Company Deep Dive
Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.
ICE.WA
SellHot AirMedinice S.A. · Healthcare · Poland · $200M · Avg Vol: $434K/d
COMPANY DESCRIPTION
Medinice S.A. is a medical technology company focused on the development and commercialization of minimally invasive devices for interventional cardiology and cardiac surgery. The company's competitive position is secured by a robust portfolio of international patents and clinical-stage proprietary technologies. It operates as a high-growth R&D-stage medical device developer.
FINANCIAL SUMMARY (PLN)
| Year | 2022 | 2023 | 2024 | 2025 | CAGR | TTM | 2027E | Fwd CAGR |
|---|---|---|---|---|---|---|---|---|
| Revenue | 0.2M | 0.2M | 0.2M | 0 | -12.6% | — | 36.0M | 476.4% |
| EPS (PLN) | -0.79 | -0.79 | 5.62 | -0.86 | — | -0.91 | — | — |
| Shares | 6.3M | 6.5M | 7.7M | 9.1M | +45.2% | 10.5M | — | — |
| Debt | 0.6M | 0.5M | 0.3M | 0.4M | -14.4% | — | — | — |
| Equity | 37.1M | 33.2M | 81.0M | 88.1M | 33.4% | — | — | — |
| Op CF | -2.8M | -3.4M | -3.7M | -5.6M | — | -5.9M | — | — |
| Inv CF | -4.1M | -6.7M | -7.3M | -6.1M | — | — | — | — |
| Fin CF | -3.9M | -0.7M | 9.8M | 12.1M | — | — | — | — |
SCORE BREAKDOWN
FUNDAMENTALS
SECTOR PEERS
Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of ICE.WA are excluded.
| Ticker | Company | Mkt Cap | StockRank | Signal |
|---|---|---|---|---|
| ICE.WA | Medinice S.A.(you) | $200M | 25 | Sell |
| MDG.WA | Medicalgorithmics S.A. | $75M | 16 | Strong Sell |
| SNT.WA | Synektik Spólka Akcyjna | $763M | 64 | Hold |
| GMT.WA | Genomtec S.A. | $17M | 1 | Strong Sell |
| BCX.WA | Bioceltix S.A. | $118M | 18 | Strong Sell |
| SLV.WA | Selvita S.A. | $132M | 40 | Hold |
| CLN.WA | Celon Pharma S.A. | $231M | 46 | Hold |
| SCP.WA | Scope Fluidics S.A. | $116M | 11 | Strong Sell |
| S2B.WA | Syn2bio S.A. | $148M | 3 | Strong Sell |
| CTX.WA | Captor Therapeutics Spolka Akcyjna | $120M | 6 | Strong Sell |
Peer medians: ROE -19.0% · P/E 17.0x · Gross margin 32.5%